Biotech leaders rally behind Chinese scientists in US, calls for 'measured' policies in wake of purges
A slate of biotech executives, venture capitalists and academic researchers have lent their voices to Chinese scientists working in the US biomedical field, amplifying concerns that recent sanctions could “create a climate of fear and uncertainty.”
The letter — drafted by Steven Holtzman, Ron Cohen, Jeremy Levin and John Maraganore and signed by well over 100 industry figures — cautions against vilifying or excluding an ethnic group at the expense of the universal effort to fight disease. Levin currently chairs BIO, while Cohen and Maraganore are past heads of the trade group.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
